Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
Stanford University · Massachusetts General Hospital · +13 more institutions
Abstract
Cytokines dimerize two receptor chains to activate Janus kinases and signal transducer and activator of transcription (STAT) transcription factors that regulate immune cells, but they have therapeutic liabilities. We engineered “Trikines” to compel cis formation of three-chain cytokine receptor complexes at the cell surface that induce bespoke STAT transcriptional signaling programs. Trikines coactivated phosphorylation of STAT5 (pSTAT5) and pSTAT3 signatures distinct from natural cytokines by assembling trimeric combinations of interleukin-2 (IL-2), IL-10, and IL-21 receptors. In preclinical models, an IL-2–based Trikine restrained terminal differentiation of T cells, promoted stemness, and enhanced…
Citation impact
- FWCI
- 58.90
- Percentile
- 100%
- References
- 67
Authors
37Topics & keywords
- stat
- Immune system
- JAK-STAT signaling pathway
- Cytokine
- Cell
- Signal transduction
- Janus kinase
- Transcription factor
Funding
- NSNational Science FoundationAward: DGE 1752814
- HHHoward Hughes Medical Institute
- CRCancer Research Institute
- SUStanford University
- UOUniversity of California
- HFHertz Foundation
- VAVirginia and D.K. Ludwig Fund for Cancer Research
- LILudwig Institute for Cancer Research
- PIParker Institute for Cancer Immunotherapy
- MFMark Foundation For Cancer Research
- NINational Institutes of HealthAwards: P30 CA014051-49, AI-51321, 3 U54 CA 244711 01, R37CA273074, AI55577, CA270790, R01AI169188, R01AI158488
- SOSchool of Medicine, Stanford UniversityAward: T32-GM007365
- NCNational Cancer InstituteAwards: 4K00CA274708, 1R37CA273819-01A1
- NSNational Science Foundation Graduate Research Fellowship Program